← Back to ICCC

ImmuCell Corporation - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 13/08/2026Mar 2026Filed 14/05/2026Sep 2025Filed 13/11/2025Jun 2025Filed 13/08/2026Mar 2025Filed 14/05/2026Sep 2024Filed 13/11/2025Jun 2024Filed 14/08/2025Mar 2024Filed 14/05/2025
$7.2$10$5.5$6.4$8.1$6$5.5$7.3
$1.8$1.9−$0.1$0.5$1.4−$0.7−$1.5−$0.4
$0.20$0.21−$0.02$0.06$0.16−$0.09−$0.20−$0.06
9.299998.27.87.8

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.